Abstract

Cardiovascular consultants are increasingly faced with patients presenting with multiple comorbidities or structural challenges, who are in need for anatomical corrections. In such patients, hybrid cardiovascular procedures often allow for collaborative therapies that integrate the strengths of percutaneous and traditional open surgical treatments, to provide an overarching treatment that cannot be provided by either approach in isolation. While the concept of hybrid cardiovascular therapy is not new, it has seen a resurgence in recent years, with the developement of new devices and approaches. Areas of particular growth within hybrid cardiovascular care include hybrid myocardial revascularization, hybrid therapies for valvular and structural heart diseases and hybrid procedures for aortic diseases. Future growth in this field is inevitable and represents an exciting frontier in cardiovascular medicine.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call